Journal article icon

Journal article

High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response

Abstract:
How human genetic variation contributes to vaccine effectiveness in infants is unclear, and data are limited on these relationships in populations with African ancestries. We undertook genetic analyses of vaccine antibody responses in infants from Uganda (n = 1391), Burkina Faso (n = 353) and South Africa (n = 755), identifying associations between human leukocyte antigen (HLA) and antibody response for five of eight tested antigens spanning pertussis, diphtheria and hepatitis B vaccines. In addition, through HLA typing 1,702 individuals from 11 populations of African ancestry derived predominantly from the 1000 Genomes Project, we constructed an imputation resource, fine-mapping class II HLA-DR and DQ associations explaining up to 10% of antibody response variance in our infant cohorts. We observed differences in the genetic architecture of pertussis antibody response between the cohorts with African ancestries and an independent cohort with European ancestry, but found no in silico evidence of differences in HLA peptide binding affinity or breadth. Using immune cell expression quantitative trait loci datasets derived from African-ancestry samples from the 1000 Genomes Project, we found evidence of differential HLA-DRB1 expression correlating with inferred protection from pertussis following vaccination. This work suggests that HLA-DRB1 expression may play a role in vaccine response and should be considered alongside peptide selection to improve vaccine design.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41591-024-02944-5

Authors


More by this author
Institution:
University of Oxford
Department:
Big Data Institute
Role:
Author
ORCID:
0000-0002-4502-2209
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Role:
Author
ORCID:
0000-0001-8738-0920
More by this author
Role:
Author
ORCID:
0000-0001-9996-6929


More from this funder
Funder identifier:
https://ror.org/00c489v88


Publisher:
Nature Research
Journal:
Nature Medicine More from this journal
Volume:
30
Issue:
5
Pages:
1384-1394
Publication date:
2024-05-13
Acceptance date:
2024-03-25
DOI:
EISSN:
1546-170X
ISSN:
1078-8956


Language:
English
Pubs id:
1996360
Local pid:
pubs:1996360
Source identifiers:
1986213
Deposit date:
2024-07-20
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP